Comparison of Atezolizumab/Bevacizumab Versus Durvalumab/Tremelimumab (STRIDE) Protocols in Locally Advanced or Metastatic Hepatocellular Carcinoma Among Patients in Sohag
Clinical trial NCT07669597 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07669597
- Sponsor
- Sohag Oncology Center
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-03-01
- Primary completion
- 2027-03-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.